SCI Slashes 2026 Earnings Outlook Amid Pending Securities Investigation
Oct 29, 2026, 9:32 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The combination of softer 2026 guidance and a confirmed securities-law investigation elevates risk perception, likely pressuring SCI stock in the near term; similar cases show initial volatility around lawsuits even when fundamentals temporarily improve.
AI summary
What happened, with direct paths to the underlying reporting
SCI lowers its 2026 adjusted EPS outlook to $3.94-$4.04, triggering an 11.6% open drop. Q3 EPS was $0.97 vs $0.98; Q4 guidance is $1.10-$1.20 vs $1.33. Weaker funeral volumes and higher costs drive the revision, while a pending securities-law investigation adds potential legal risk. Near-term pressure could persist until earnings visibility and investigation clarity improve.
SCI lowers 2026 adjusted EPS to $3.94-$4.04; stock falls ~11.6%.
Q3 EPS $0.97 vs $0.98; Q4 guidance $1.10-$1.20 vs $1.33.
Weaker funeral volumes and higher operating costs drive the revision.
Pending securities-law investigation by Levi & Korsinsky adds legal risk.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event